nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—CYP2C8—Sorafenib—thyroid cancer	0.107	0.394	CbGbCtD
Tolbutamide—CYP2C19—Sorafenib—thyroid cancer	0.0899	0.331	CbGbCtD
Tolbutamide—Glipizide—PPARG—thyroid cancer	0.0849	1	CrCbGaD
Tolbutamide—CYP2C9—Sorafenib—thyroid cancer	0.0747	0.275	CbGbCtD
Tolbutamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0215	0.0605	CbGpPWpGaD
Tolbutamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0209	0.0586	CbGpPWpGaD
Tolbutamide—Hypoglycaemia—Vandetanib—thyroid cancer	0.0186	0.0648	CcSEcCtD
Tolbutamide—SLCO2B1—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.0184	0.0516	CbGpPWpGaD
Tolbutamide—Hyponatraemia—Vandetanib—thyroid cancer	0.0182	0.0635	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0143	0.0499	CcSEcCtD
Tolbutamide—SLCO1A2—Recycling of bile acids and salts—RXRA—thyroid cancer	0.0129	0.0363	CbGpPWpGaD
Tolbutamide—Hyponatraemia—Sorafenib—thyroid cancer	0.0123	0.0428	CcSEcCtD
Tolbutamide—Eruption—Epirubicin—thyroid cancer	0.0101	0.0353	CcSEcCtD
Tolbutamide—Eruption—Doxorubicin—thyroid cancer	0.00939	0.0327	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vandetanib—thyroid cancer	0.00875	0.0304	CcSEcCtD
Tolbutamide—ABCC8—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00872	0.0245	CbGpPWpGaD
Tolbutamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—thyroid cancer	0.00858	0.0241	CbGpPWpGaD
Tolbutamide—KCNJ11—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00846	0.0238	CbGpPWpGaD
Tolbutamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—thyroid cancer	0.00796	0.0224	CbGpPWpGaD
Tolbutamide—Dyspepsia—Vandetanib—thyroid cancer	0.00786	0.0274	CcSEcCtD
Tolbutamide—CYP2C18—Metapathway biotransformation—CHST14—thyroid cancer	0.00773	0.0217	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00771	0.0268	CcSEcCtD
Tolbutamide—Erythema—Sorafenib—thyroid cancer	0.00738	0.0257	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Epirubicin—thyroid cancer	0.0071	0.0247	CcSEcCtD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00707	0.0199	CbGpPWpGaD
Tolbutamide—ABCC8—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00686	0.0193	CbGpPWpGaD
Tolbutamide—SLCO1A2—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00676	0.019	CbGpPWpGaD
Tolbutamide—KCNJ11—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00665	0.0187	CbGpPWpGaD
Tolbutamide—Leukopenia—Sorafenib—thyroid cancer	0.00661	0.023	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00657	0.0229	CcSEcCtD
Tolbutamide—Pruritus—Vandetanib—thyroid cancer	0.00632	0.022	CcSEcCtD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00631	0.0177	CbGpPWpGaD
Tolbutamide—Thrombocytopenia—Sorafenib—thyroid cancer	0.0059	0.0205	CcSEcCtD
Tolbutamide—Aplastic anaemia—Epirubicin—thyroid cancer	0.00586	0.0204	CcSEcCtD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00575	0.0162	CbGpPWpGaD
Tolbutamide—Rash—Vandetanib—thyroid cancer	0.00563	0.0196	CcSEcCtD
Tolbutamide—Headache—Vandetanib—thyroid cancer	0.0056	0.0195	CcSEcCtD
Tolbutamide—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00542	0.0189	CcSEcCtD
Tolbutamide—Nausea—Vandetanib—thyroid cancer	0.00531	0.0185	CcSEcCtD
Tolbutamide—Dyspepsia—Sorafenib—thyroid cancer	0.0053	0.0185	CcSEcCtD
Tolbutamide—CYP2C18—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.0053	0.0149	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0052	0.0181	CcSEcCtD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00505	0.0142	CbGpPWpGaD
Tolbutamide—Urticaria—Sorafenib—thyroid cancer	0.00479	0.0167	CcSEcCtD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00469	0.0132	CbGpPWpGaD
Tolbutamide—Hypoglycaemia—Epirubicin—thyroid cancer	0.00464	0.0162	CcSEcCtD
Tolbutamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00457	0.0128	CbGpPWpGaD
Tolbutamide—Hyponatraemia—Epirubicin—thyroid cancer	0.00455	0.0158	CcSEcCtD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.0043	0.0121	CbGpPWpGaD
Tolbutamide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.0043	0.0149	CcSEcCtD
Tolbutamide—Pruritus—Sorafenib—thyroid cancer	0.00426	0.0148	CcSEcCtD
Tolbutamide—Hyponatraemia—Doxorubicin—thyroid cancer	0.00421	0.0146	CcSEcCtD
Tolbutamide—Abdominal distension—Epirubicin—thyroid cancer	0.00394	0.0137	CcSEcCtD
Tolbutamide—Rash—Sorafenib—thyroid cancer	0.0038	0.0132	CcSEcCtD
Tolbutamide—Headache—Sorafenib—thyroid cancer	0.00377	0.0131	CcSEcCtD
Tolbutamide—Pancytopenia—Epirubicin—thyroid cancer	0.00372	0.0129	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—thyroid cancer	0.00365	0.0127	CcSEcCtD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.0036	0.0101	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.0036	0.0101	CbGpPWpGaD
Tolbutamide—Nausea—Sorafenib—thyroid cancer	0.00358	0.0125	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00357	0.0124	CcSEcCtD
Tolbutamide—Pancytopenia—Doxorubicin—thyroid cancer	0.00344	0.012	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00331	0.0115	CcSEcCtD
Tolbutamide—Agranulocytosis—Epirubicin—thyroid cancer	0.00326	0.0113	CcSEcCtD
Tolbutamide—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00326	0.00915	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.00322	0.00904	CbGpPWpGaD
Tolbutamide—Agranulocytosis—Doxorubicin—thyroid cancer	0.00301	0.0105	CcSEcCtD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00301	0.00847	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00301	0.00847	CbGpPWpGaD
Tolbutamide—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00297	0.00834	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.00287	0.00807	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.0028	0.00786	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.0028	0.00786	CbGpPWpGaD
Tolbutamide—Erythema—Epirubicin—thyroid cancer	0.00273	0.0095	CcSEcCtD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.0027	0.00757	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.00262	0.00736	CbGpPWpGaD
Tolbutamide—Erythema—Doxorubicin—thyroid cancer	0.00252	0.00879	CcSEcCtD
Tolbutamide—Leukopenia—Epirubicin—thyroid cancer	0.00244	0.0085	CcSEcCtD
Tolbutamide—KCNJ1—Neuronal System—BRAF—thyroid cancer	0.0024	0.00673	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—RXRA—thyroid cancer	0.00228	0.00641	CbGpPWpGaD
Tolbutamide—Leukopenia—Doxorubicin—thyroid cancer	0.00226	0.00786	CcSEcCtD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00226	0.00634	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00221	0.00621	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00221	0.00621	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00221	0.0062	CbGpPWpGaD
Tolbutamide—Thrombocytopenia—Epirubicin—thyroid cancer	0.00218	0.00759	CcSEcCtD
Tolbutamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00218	0.00612	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MINPP1—thyroid cancer	0.00215	0.00605	CbGpPWpGaD
Tolbutamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00211	0.00593	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00209	0.00588	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MINPP1—thyroid cancer	0.00209	0.00587	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00208	0.00583	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00208	0.00583	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00206	0.00578	CbGpPWpGaD
Tolbutamide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00202	0.00702	CcSEcCtD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00197	0.00553	CbGpPWpGaD
Tolbutamide—Dyspepsia—Epirubicin—thyroid cancer	0.00196	0.00682	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00192	0.00669	CcSEcCtD
Tolbutamide—ABCC8—Metabolism—NDUFA13—thyroid cancer	0.00183	0.00514	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00183	0.00514	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—CP—thyroid cancer	0.00183	0.00514	CbGpPWpGaD
Tolbutamide—Dyspepsia—Doxorubicin—thyroid cancer	0.00181	0.00631	CcSEcCtD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.0018	0.00506	CbGpPWpGaD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.0018	0.00505	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00179	0.00503	CbGpPWpGaD
Tolbutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00179	0.00502	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00178	0.00619	CcSEcCtD
Tolbutamide—KCNJ11—Metabolism—NDUFA13—thyroid cancer	0.00178	0.00499	CbGpPWpGaD
Tolbutamide—Urticaria—Epirubicin—thyroid cancer	0.00177	0.00616	CcSEcCtD
Tolbutamide—ABCC8—Metabolism—CHST14—thyroid cancer	0.00172	0.00484	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.0017	0.00478	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—CP—thyroid cancer	0.0017	0.00478	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MINPP1—thyroid cancer	0.00168	0.00471	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00167	0.0047	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CHST14—thyroid cancer	0.00167	0.00469	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00165	0.00465	CbGpPWpGaD
Tolbutamide—Urticaria—Doxorubicin—thyroid cancer	0.00164	0.0057	CcSEcCtD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.0016	0.00449	CbGpPWpGaD
Tolbutamide—Pruritus—Epirubicin—thyroid cancer	0.00158	0.00548	CcSEcCtD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00155	0.00437	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.00153	0.0043	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00153	0.0043	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00151	0.00423	CbGpPWpGaD
Tolbutamide—Pruritus—Doxorubicin—thyroid cancer	0.00146	0.00507	CcSEcCtD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00146	0.00409	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NDUFA13—thyroid cancer	0.00143	0.00401	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.00142	0.00399	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00142	0.00399	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MINPP1—thyroid cancer	0.00142	0.00399	CbGpPWpGaD
Tolbutamide—Rash—Epirubicin—thyroid cancer	0.0014	0.00489	CcSEcCtD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.0014	0.00393	CbGpPWpGaD
Tolbutamide—Headache—Epirubicin—thyroid cancer	0.0014	0.00485	CcSEcCtD
Tolbutamide—ABCC8—Metabolism—HPGD—thyroid cancer	0.00139	0.0039	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00137	0.00385	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—HPGD—thyroid cancer	0.00135	0.00378	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CHST14—thyroid cancer	0.00134	0.00377	CbGpPWpGaD
Tolbutamide—Nausea—Epirubicin—thyroid cancer	0.00132	0.0046	CcSEcCtD
Tolbutamide—Rash—Doxorubicin—thyroid cancer	0.0013	0.00452	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—thyroid cancer	0.00129	0.00449	CcSEcCtD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00127	0.00358	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00127	0.00356	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—BRAF—thyroid cancer	0.00122	0.00344	CbGpPWpGaD
Tolbutamide—Nausea—Doxorubicin—thyroid cancer	0.00122	0.00426	CcSEcCtD
Tolbutamide—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.00121	0.00339	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—BRAF—thyroid cancer	0.00119	0.00333	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00115	0.00323	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00115	0.00322	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.00114	0.00319	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00113	0.00318	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.00112	0.00315	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00112	0.00315	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.0011	0.0031	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—HRAS—thyroid cancer	0.0011	0.00309	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HPGD—thyroid cancer	0.00108	0.00304	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00107	0.00301	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00106	0.00299	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.00106	0.00296	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00106	0.00296	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00104	0.00292	CbGpPWpGaD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00103	0.0029	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00101	0.00284	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000964	0.00271	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.00095	0.00267	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HPGD—thyroid cancer	0.000916	0.00257	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000902	0.00253	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000894	0.00251	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000848	0.00238	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000841	0.00236	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000822	0.00231	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TPR—thyroid cancer	0.000797	0.00224	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00079	0.00222	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PRKAR1A—thyroid cancer	0.000784	0.0022	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000774	0.00217	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TPR—thyroid cancer	0.000773	0.00217	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PRKAR1A—thyroid cancer	0.00076	0.00214	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000743	0.00209	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000706	0.00198	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MINPP1—thyroid cancer	0.000698	0.00196	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000664	0.00186	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000623	0.00175	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TPR—thyroid cancer	0.000621	0.00174	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	0.000611	0.00172	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SLC5A5—thyroid cancer	0.000597	0.00168	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NDUFA13—thyroid cancer	0.000594	0.00167	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC5A5—thyroid cancer	0.000579	0.00163	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MINPP1—thyroid cancer	0.000568	0.0016	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—HRAS—thyroid cancer	0.000563	0.00158	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CHST14—thyroid cancer	0.000558	0.00157	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—HRAS—thyroid cancer	0.000546	0.00153	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NDUFA13—thyroid cancer	0.00053	0.00149	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TPR—thyroid cancer	0.000526	0.00148	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	0.000517	0.00145	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—RXRA—thyroid cancer	0.000501	0.00141	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CHST14—thyroid cancer	0.000498	0.0014	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—RXRA—thyroid cancer	0.000486	0.00137	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NDUFA13—thyroid cancer	0.000483	0.00136	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000469	0.00132	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC5A5—thyroid cancer	0.000465	0.00131	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CHST14—thyroid cancer	0.000454	0.00128	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HPGD—thyroid cancer	0.00045	0.00126	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HPGD—thyroid cancer	0.000402	0.00113	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	0.000394	0.00111	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—RXRA—thyroid cancer	0.000391	0.0011	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000369	0.00104	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HPGD—thyroid cancer	0.000366	0.00103	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000365	0.00103	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—RXRA—thyroid cancer	0.000331	0.000929	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000326	0.000915	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000322	0.000904	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PPARG—thyroid cancer	0.000316	0.000889	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PPARG—thyroid cancer	0.000307	0.000862	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000297	0.000834	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TPR—thyroid cancer	0.000258	0.000726	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	0.000254	0.000714	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS2—thyroid cancer	0.000249	0.000699	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PPARG—thyroid cancer	0.000247	0.000693	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS2—thyroid cancer	0.000241	0.000678	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TPR—thyroid cancer	0.000231	0.000648	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.00023	0.000647	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	0.000227	0.000637	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTEN—thyroid cancer	0.000217	0.00061	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTEN—thyroid cancer	0.000211	0.000591	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TPR—thyroid cancer	0.00021	0.000591	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PPARG—thyroid cancer	0.000209	0.000587	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	0.000207	0.000581	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000206	0.000578	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS2—thyroid cancer	0.000194	0.000545	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC5A5—thyroid cancer	0.000193	0.000543	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000188	0.000527	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000181	0.000509	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC5A5—thyroid cancer	0.000173	0.000485	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTEN—thyroid cancer	0.000169	0.000475	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS2—thyroid cancer	0.000164	0.000462	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—RXRA—thyroid cancer	0.000163	0.000457	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000162	0.000455	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000158	0.000444	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC5A5—thyroid cancer	0.000157	0.000442	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000148	0.000414	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—RXRA—thyroid cancer	0.000145	0.000408	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTEN—thyroid cancer	0.000143	0.000402	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000141	0.000396	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—RXRA—thyroid cancer	0.000132	0.000372	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000129	0.000361	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKT1—thyroid cancer	0.000125	0.000351	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKT1—thyroid cancer	0.000121	0.000341	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPARG—thyroid cancer	0.000103	0.000288	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKT1—thyroid cancer	9.75e-05	0.000274	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPARG—thyroid cancer	9.16e-05	0.000257	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPARG—thyroid cancer	8.35e-05	0.000235	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKT1—thyroid cancer	8.26e-05	0.000232	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS2—thyroid cancer	8.07e-05	0.000227	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS2—thyroid cancer	7.21e-05	0.000202	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTEN—thyroid cancer	7.04e-05	0.000198	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS2—thyroid cancer	6.57e-05	0.000185	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTEN—thyroid cancer	6.28e-05	0.000177	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTEN—thyroid cancer	5.73e-05	0.000161	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKT1—thyroid cancer	4.06e-05	0.000114	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKT1—thyroid cancer	3.62e-05	0.000102	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKT1—thyroid cancer	3.3e-05	9.28e-05	CbGpPWpGaD
